nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Meniere's disease—Varenicline—nicotine dependence	0.0348	0.0395	CcSEcCtD
Escitalopram—Costochondritis—Varenicline—nicotine dependence	0.0277	0.0314	CcSEcCtD
Escitalopram—Change of bowel habit—Varenicline—nicotine dependence	0.0252	0.0285	CcSEcCtD
Escitalopram—Terminal insomnia—Varenicline—nicotine dependence	0.0232	0.0262	CcSEcCtD
Escitalopram—Snoring—Varenicline—nicotine dependence	0.02	0.0227	CcSEcCtD
Escitalopram—Postnasal drip—Varenicline—nicotine dependence	0.0188	0.0213	CcSEcCtD
Escitalopram—Middle insomnia—Varenicline—nicotine dependence	0.0177	0.02	CcSEcCtD
Escitalopram—Hypogeusia—Varenicline—nicotine dependence	0.0167	0.019	CcSEcCtD
Escitalopram—Initial insomnia—Varenicline—nicotine dependence	0.0159	0.018	CcSEcCtD
Escitalopram—Chest wall pain—Varenicline—nicotine dependence	0.0159	0.018	CcSEcCtD
Escitalopram—Upper-airway cough syndrome—Varenicline—nicotine dependence	0.0159	0.018	CcSEcCtD
Escitalopram—Panic reaction—Varenicline—nicotine dependence	0.0145	0.0164	CcSEcCtD
Escitalopram—Emotional disorder—Varenicline—nicotine dependence	0.0133	0.0151	CcSEcCtD
Escitalopram—Gingival pain—Varenicline—nicotine dependence	0.0133	0.0151	CcSEcCtD
Escitalopram—Myopia—Varenicline—nicotine dependence	0.0133	0.0151	CcSEcCtD
Escitalopram—Night blindness—Varenicline—nicotine dependence	0.0123	0.014	CcSEcCtD
Escitalopram—Restless legs syndrome—Varenicline—nicotine dependence	0.0102	0.0115	CcSEcCtD
Escitalopram—Joint stiffness—Varenicline—nicotine dependence	0.00962	0.0109	CcSEcCtD
Escitalopram—Sensory disturbance—Varenicline—nicotine dependence	0.00937	0.0106	CcSEcCtD
Escitalopram—Facial paralysis—Varenicline—nicotine dependence	0.00913	0.0103	CcSEcCtD
Escitalopram—Anger—Varenicline—nicotine dependence	0.00813	0.00921	CcSEcCtD
Escitalopram—Peripheral ischaemia—Varenicline—nicotine dependence	0.00796	0.00902	CcSEcCtD
Escitalopram—Varicose vein—Varenicline—nicotine dependence	0.0078	0.00883	CcSEcCtD
Escitalopram—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.00749	0.00848	CcSEcCtD
Escitalopram—Coronary artery disease—Varenicline—nicotine dependence	0.00735	0.00832	CcSEcCtD
Escitalopram—Haematochezia—Varenicline—nicotine dependence	0.00721	0.00817	CcSEcCtD
Escitalopram—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00708	0.00802	CcSEcCtD
Escitalopram—Depressed mood—Varenicline—nicotine dependence	0.00649	0.00736	CcSEcCtD
Escitalopram—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00648	0.0553	CbGpPWpGaD
Escitalopram—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00596	0.0509	CbGpPWpGaD
Escitalopram—Sinus congestion—Varenicline—nicotine dependence	0.00584	0.00661	CcSEcCtD
Escitalopram—Transient ischaemic attack—Varenicline—nicotine dependence	0.00575	0.00652	CcSEcCtD
Escitalopram—Throat irritation—Varenicline—nicotine dependence	0.00575	0.00652	CcSEcCtD
Escitalopram—Suicide—Varenicline—nicotine dependence	0.0056	0.00634	CcSEcCtD
Escitalopram—Night sweats—Varenicline—nicotine dependence	0.00538	0.00609	CcSEcCtD
Escitalopram—Balance disorder—Varenicline—nicotine dependence	0.00531	0.00602	CcSEcCtD
Escitalopram—Urine abnormality—Varenicline—nicotine dependence	0.00525	0.00594	CcSEcCtD
Escitalopram—Hostility—Varenicline—nicotine dependence	0.00525	0.00594	CcSEcCtD
Escitalopram—Sexual dysfunction—Varenicline—nicotine dependence	0.00518	0.00587	CcSEcCtD
Escitalopram—Osteoporosis—Varenicline—nicotine dependence	0.00518	0.00587	CcSEcCtD
Escitalopram—Suicide attempt—Varenicline—nicotine dependence	0.00512	0.0058	CcSEcCtD
Escitalopram—Gastric ulcer—Varenicline—nicotine dependence	0.005	0.00566	CcSEcCtD
Escitalopram—Urine analysis abnormal—Varenicline—nicotine dependence	0.00494	0.00559	CcSEcCtD
Escitalopram—Completed suicide—Varenicline—nicotine dependence	0.00494	0.00559	CcSEcCtD
Escitalopram—Platelet count decreased—Varenicline—nicotine dependence	0.00488	0.00553	CcSEcCtD
Escitalopram—Toothache—Varenicline—nicotine dependence	0.00477	0.00541	CcSEcCtD
Escitalopram—Vaginal discharge—Varenicline—nicotine dependence	0.00477	0.00541	CcSEcCtD
Escitalopram—Libido increased—Varenicline—nicotine dependence	0.00477	0.00541	CcSEcCtD
Escitalopram—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00465	0.0397	CbGpPWpGaD
Escitalopram—Psoriasis—Varenicline—nicotine dependence	0.00462	0.00523	CcSEcCtD
Escitalopram—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00443	0.00502	CcSEcCtD
Escitalopram—Upset stomach—Varenicline—nicotine dependence	0.00443	0.00502	CcSEcCtD
Escitalopram—Cyst—Varenicline—nicotine dependence	0.00434	0.00492	CcSEcCtD
Escitalopram—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0043	0.00487	CcSEcCtD
Escitalopram—Menstrual disorder—Varenicline—nicotine dependence	0.00426	0.00483	CcSEcCtD
Escitalopram—Paranoia—Varenicline—nicotine dependence	0.00426	0.00483	CcSEcCtD
Escitalopram—Laryngeal pain—Varenicline—nicotine dependence	0.00426	0.00483	CcSEcCtD
Escitalopram—Haematemesis—Varenicline—nicotine dependence	0.00418	0.00473	CcSEcCtD
Escitalopram—Suicidal ideation—Varenicline—nicotine dependence	0.00414	0.00469	CcSEcCtD
Escitalopram—Thrombosis—Varenicline—nicotine dependence	0.0041	0.00465	CcSEcCtD
Escitalopram—Delusion—Varenicline—nicotine dependence	0.0041	0.00465	CcSEcCtD
Escitalopram—Nystagmus—Varenicline—nicotine dependence	0.00407	0.0046	CcSEcCtD
Escitalopram—Hyperlipidaemia—Varenicline—nicotine dependence	0.00403	0.00456	CcSEcCtD
Escitalopram—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00402	0.0343	CbGpPWpGaD
Escitalopram—Mania—Varenicline—nicotine dependence	0.00399	0.00452	CcSEcCtD
Escitalopram—Menorrhagia—Varenicline—nicotine dependence	0.00392	0.00444	CcSEcCtD
Escitalopram—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00386	0.00437	CcSEcCtD
Escitalopram—Scotoma—Varenicline—nicotine dependence	0.00382	0.00433	CcSEcCtD
Escitalopram—Fungal infection—Varenicline—nicotine dependence	0.00376	0.00426	CcSEcCtD
Escitalopram—Gingivitis—Varenicline—nicotine dependence	0.0037	0.00419	CcSEcCtD
Escitalopram—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0037	0.0316	CbGpPWpGaD
Escitalopram—Mydriasis—Varenicline—nicotine dependence	0.00364	0.00412	CcSEcCtD
Escitalopram—Nephrolithiasis—Varenicline—nicotine dependence	0.00361	0.00409	CcSEcCtD
Escitalopram—Rhinorrhoea—Varenicline—nicotine dependence	0.00358	0.00406	CcSEcCtD
Escitalopram—Dysphonia—Varenicline—nicotine dependence	0.00353	0.004	CcSEcCtD
Escitalopram—Endocrine disorder—Varenicline—nicotine dependence	0.0035	0.00397	CcSEcCtD
Escitalopram—Acne—Varenicline—nicotine dependence	0.00345	0.00391	CcSEcCtD
Escitalopram—Eye irritation—Varenicline—nicotine dependence	0.0034	0.00385	CcSEcCtD
Escitalopram—Disturbance in attention—Varenicline—nicotine dependence	0.00335	0.0038	CcSEcCtD
Escitalopram—Aggression—Varenicline—nicotine dependence	0.00331	0.00374	CcSEcCtD
Escitalopram—Chest discomfort—Varenicline—nicotine dependence	0.00328	0.00372	CcSEcCtD
Escitalopram—Accidental injury—Varenicline—nicotine dependence	0.00328	0.00372	CcSEcCtD
Escitalopram—Viral infection—Varenicline—nicotine dependence	0.00322	0.00364	CcSEcCtD
Escitalopram—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00322	0.00364	CcSEcCtD
Escitalopram—Thinking abnormal—Varenicline—nicotine dependence	0.00317	0.00359	CcSEcCtD
Escitalopram—Nocturia—Varenicline—nicotine dependence	0.00313	0.00355	CcSEcCtD
Escitalopram—Leukocytosis—Varenicline—nicotine dependence	0.00309	0.0035	CcSEcCtD
Escitalopram—Dysarthria—Varenicline—nicotine dependence	0.00307	0.00348	CcSEcCtD
Escitalopram—Coordination abnormal—Varenicline—nicotine dependence	0.00296	0.00335	CcSEcCtD
Escitalopram—Musculoskeletal pain—Varenicline—nicotine dependence	0.00294	0.00333	CcSEcCtD
Escitalopram—Pulmonary embolism—Varenicline—nicotine dependence	0.0029	0.00329	CcSEcCtD
Escitalopram—Blood pressure increased—Varenicline—nicotine dependence	0.0029	0.00329	CcSEcCtD
Escitalopram—Abnormal dreams—Varenicline—nicotine dependence	0.00287	0.00325	CcSEcCtD
Escitalopram—Eructation—Varenicline—nicotine dependence	0.00285	0.00323	CcSEcCtD
Escitalopram—Salivary hypersecretion—Varenicline—nicotine dependence	0.00282	0.00319	CcSEcCtD
Escitalopram—Influenza like illness—Varenicline—nicotine dependence	0.00282	0.00319	CcSEcCtD
Escitalopram—Nightmare—Varenicline—nicotine dependence	0.0028	0.00318	CcSEcCtD
Escitalopram—Photophobia—Varenicline—nicotine dependence	0.00273	0.00309	CcSEcCtD
Escitalopram—Dry eye—Varenicline—nicotine dependence	0.00268	0.00304	CcSEcCtD
Escitalopram—Oesophagitis—Varenicline—nicotine dependence	0.00265	0.00301	CcSEcCtD
Escitalopram—Urine output increased—Varenicline—nicotine dependence	0.00263	0.00297	CcSEcCtD
Escitalopram—Mouth ulceration—Varenicline—nicotine dependence	0.00263	0.00297	CcSEcCtD
Escitalopram—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00258	0.022	CbGpPWpGaD
Escitalopram—Hypertonia—Varenicline—nicotine dependence	0.00255	0.00288	CcSEcCtD
Escitalopram—Mental disability—Varenicline—nicotine dependence	0.00252	0.00285	CcSEcCtD
Escitalopram—Euphoric mood—Varenicline—nicotine dependence	0.0025	0.00283	CcSEcCtD
Escitalopram—Lymphadenopathy—Varenicline—nicotine dependence	0.00247	0.0028	CcSEcCtD
Escitalopram—Sleep disorder—Varenicline—nicotine dependence	0.00244	0.00276	CcSEcCtD
Escitalopram—Diabetes mellitus—Varenicline—nicotine dependence	0.00242	0.00275	CcSEcCtD
Escitalopram—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00242	0.0206	CbGpPWpGaD
Escitalopram—Polyuria—Varenicline—nicotine dependence	0.0024	0.00272	CcSEcCtD
Escitalopram—Deafness—Varenicline—nicotine dependence	0.00236	0.00267	CcSEcCtD
Escitalopram—Disorientation—Varenicline—nicotine dependence	0.00236	0.00267	CcSEcCtD
Escitalopram—Eczema—Varenicline—nicotine dependence	0.00235	0.00266	CcSEcCtD
Escitalopram—Eye pain—Varenicline—nicotine dependence	0.00234	0.00264	CcSEcCtD
Escitalopram—Injury—Varenicline—nicotine dependence	0.00229	0.0026	CcSEcCtD
Escitalopram—Renal failure acute—Varenicline—nicotine dependence	0.00228	0.00259	CcSEcCtD
Escitalopram—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00228	0.0194	CbGpPWpGaD
Escitalopram—Libido decreased—Varenicline—nicotine dependence	0.00227	0.00257	CcSEcCtD
Escitalopram—Hot flush—Varenicline—nicotine dependence	0.00225	0.00255	CcSEcCtD
Escitalopram—Increased appetite—Varenicline—nicotine dependence	0.00224	0.00254	CcSEcCtD
Escitalopram—Amnesia—Varenicline—nicotine dependence	0.00224	0.00254	CcSEcCtD
Escitalopram—Menopausal symptoms—Varenicline—nicotine dependence	0.00223	0.00253	CcSEcCtD
Escitalopram—Visual disturbance—Varenicline—nicotine dependence	0.00222	0.00252	CcSEcCtD
Escitalopram—Atrial fibrillation—Varenicline—nicotine dependence	0.00222	0.00252	CcSEcCtD
Escitalopram—Thirst—Varenicline—nicotine dependence	0.00221	0.00251	CcSEcCtD
Escitalopram—Arthritis—Varenicline—nicotine dependence	0.00217	0.00246	CcSEcCtD
Escitalopram—Hypoglycaemia—Varenicline—nicotine dependence	0.00216	0.00245	CcSEcCtD
Escitalopram—Cerebrovascular accident—Varenicline—nicotine dependence	0.00215	0.00244	CcSEcCtD
Escitalopram—Lethargy—Varenicline—nicotine dependence	0.00215	0.00244	CcSEcCtD
Escitalopram—Osteoarthritis—Varenicline—nicotine dependence	0.00211	0.00239	CcSEcCtD
Escitalopram—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00211	0.00239	CcSEcCtD
Escitalopram—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00209	0.00237	CcSEcCtD
Escitalopram—Migraine—Varenicline—nicotine dependence	0.00207	0.00235	CcSEcCtD
Escitalopram—Affect lability—Varenicline—nicotine dependence	0.00207	0.00235	CcSEcCtD
Escitalopram—Psychotic disorder—Varenicline—nicotine dependence	0.00206	0.00233	CcSEcCtD
Escitalopram—Irritability—Varenicline—nicotine dependence	0.00201	0.00228	CcSEcCtD
Escitalopram—Urinary retention—Varenicline—nicotine dependence	0.002	0.00227	CcSEcCtD
Escitalopram—Mood swings—Varenicline—nicotine dependence	0.002	0.00226	CcSEcCtD
Escitalopram—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.00197	0.0168	CbGpPWpGaD
Escitalopram—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00197	0.0168	CbGpPWpGaD
Escitalopram—Liver function test abnormal—Varenicline—nicotine dependence	0.00195	0.0022	CcSEcCtD
Escitalopram—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00193	0.0165	CbGpPWpGaD
Escitalopram—Dry skin—Varenicline—nicotine dependence	0.00193	0.00219	CcSEcCtD
Escitalopram—Abdominal pain upper—Varenicline—nicotine dependence	0.00193	0.00218	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00192	0.0164	CbGpPWpGaD
Escitalopram—Hypokalaemia—Varenicline—nicotine dependence	0.00192	0.00217	CcSEcCtD
Escitalopram—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00191	0.0163	CbGpPWpGaD
Escitalopram—Breast disorder—Varenicline—nicotine dependence	0.0019	0.00216	CcSEcCtD
Escitalopram—Cramp muscle—Varenicline—nicotine dependence	0.0019	0.00215	CcSEcCtD
Escitalopram—Nasopharyngitis—Varenicline—nicotine dependence	0.00189	0.00214	CcSEcCtD
Escitalopram—Gastritis—Varenicline—nicotine dependence	0.00187	0.00211	CcSEcCtD
Escitalopram—Abdominal distension—Varenicline—nicotine dependence	0.00183	0.00208	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00182	0.0156	CbGpPWpGaD
Escitalopram—Asthma—Varenicline—nicotine dependence	0.00182	0.00206	CcSEcCtD
Escitalopram—Dysphagia—Varenicline—nicotine dependence	0.00182	0.00206	CcSEcCtD
Escitalopram—Angina pectoris—Varenicline—nicotine dependence	0.00177	0.00201	CcSEcCtD
Escitalopram—Bronchitis—Varenicline—nicotine dependence	0.00175	0.00198	CcSEcCtD
Escitalopram—Abdominal discomfort—Varenicline—nicotine dependence	0.00175	0.00198	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00173	0.0148	CbGpPWpGaD
Escitalopram—Pollakiuria—Varenicline—nicotine dependence	0.00168	0.00191	CcSEcCtD
Escitalopram—Erectile dysfunction—Varenicline—nicotine dependence	0.00168	0.0019	CcSEcCtD
Escitalopram—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00167	0.0142	CbGpPWpGaD
Escitalopram—Photosensitivity reaction—Varenicline—nicotine dependence	0.00166	0.00188	CcSEcCtD
Escitalopram—Weight increased—Varenicline—nicotine dependence	0.00166	0.00188	CcSEcCtD
Escitalopram—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00166	0.0141	CbGpPWpGaD
Escitalopram—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00165	0.0141	CbGpPWpGaD
Escitalopram—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00165	0.0141	CbGpPWpGaD
Escitalopram—Hyperglycaemia—Varenicline—nicotine dependence	0.00164	0.00186	CcSEcCtD
Escitalopram—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00163	0.0139	CbGpPWpGaD
Escitalopram—Infestation—Varenicline—nicotine dependence	0.00162	0.00184	CcSEcCtD
Escitalopram—Infestation NOS—Varenicline—nicotine dependence	0.00162	0.00184	CcSEcCtD
Escitalopram—Depression—Varenicline—nicotine dependence	0.00162	0.00183	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00161	0.00182	CcSEcCtD
Escitalopram—Acute coronary syndrome—Varenicline—nicotine dependence	0.0016	0.00181	CcSEcCtD
Escitalopram—Myocardial infarction—Varenicline—nicotine dependence	0.00159	0.0018	CcSEcCtD
Escitalopram—Stomatitis—Varenicline—nicotine dependence	0.00158	0.00179	CcSEcCtD
Escitalopram—Conjunctivitis—Varenicline—nicotine dependence	0.00158	0.00179	CcSEcCtD
Escitalopram—Hepatobiliary disease—Varenicline—nicotine dependence	0.00154	0.00174	CcSEcCtD
Escitalopram—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00153	0.0131	CbGpPWpGaD
Escitalopram—Epistaxis—Varenicline—nicotine dependence	0.00153	0.00174	CcSEcCtD
Escitalopram—Sinusitis—Varenicline—nicotine dependence	0.00152	0.00173	CcSEcCtD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00151	0.0129	CbGpPWpGaD
Escitalopram—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00151	0.0129	CbGpPWpGaD
Escitalopram—Bradycardia—Varenicline—nicotine dependence	0.00148	0.00168	CcSEcCtD
Escitalopram—Hallucination—Varenicline—nicotine dependence	0.00145	0.00164	CcSEcCtD
Escitalopram—Hypoaesthesia—Varenicline—nicotine dependence	0.00145	0.00164	CcSEcCtD
Escitalopram—Urinary tract disorder—Varenicline—nicotine dependence	0.00144	0.00163	CcSEcCtD
Escitalopram—Oedema peripheral—Varenicline—nicotine dependence	0.00144	0.00163	CcSEcCtD
Escitalopram—Connective tissue disorder—Varenicline—nicotine dependence	0.00143	0.00162	CcSEcCtD
Escitalopram—Urethral disorder—Varenicline—nicotine dependence	0.00143	0.00162	CcSEcCtD
Escitalopram—Visual impairment—Varenicline—nicotine dependence	0.00141	0.00159	CcSEcCtD
Escitalopram—SLC6A3—Neuronal System—CHRNB3—nicotine dependence	0.0014	0.0119	CbGpPWpGaD
Escitalopram—Erythema multiforme—Varenicline—nicotine dependence	0.00138	0.00156	CcSEcCtD
Escitalopram—Eye disorder—Varenicline—nicotine dependence	0.00136	0.00154	CcSEcCtD
Escitalopram—Tinnitus—Varenicline—nicotine dependence	0.00136	0.00154	CcSEcCtD
Escitalopram—Cardiac disorder—Varenicline—nicotine dependence	0.00135	0.00153	CcSEcCtD
Escitalopram—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00135	0.0115	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—CHRNA6—nicotine dependence	0.00133	0.0113	CbGpPWpGaD
Escitalopram—Angiopathy—Varenicline—nicotine dependence	0.00132	0.0015	CcSEcCtD
Escitalopram—Immune system disorder—Varenicline—nicotine dependence	0.00132	0.00149	CcSEcCtD
Escitalopram—Mediastinal disorder—Varenicline—nicotine dependence	0.00131	0.00149	CcSEcCtD
Escitalopram—Chills—Varenicline—nicotine dependence	0.00131	0.00148	CcSEcCtD
Escitalopram—Arrhythmia—Varenicline—nicotine dependence	0.0013	0.00148	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00128	0.0109	CbGpPWpGaD
Escitalopram—Mental disorder—Varenicline—nicotine dependence	0.00128	0.00145	CcSEcCtD
Escitalopram—Malnutrition—Varenicline—nicotine dependence	0.00127	0.00144	CcSEcCtD
Escitalopram—Erythema—Varenicline—nicotine dependence	0.00127	0.00144	CcSEcCtD
Escitalopram—Flatulence—Varenicline—nicotine dependence	0.00125	0.00142	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00125	0.0107	CbGpPWpGaD
Escitalopram—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00124	0.0106	CbGpPWpGaD
Escitalopram—Dysgeusia—Varenicline—nicotine dependence	0.00124	0.00141	CcSEcCtD
Escitalopram—Back pain—Varenicline—nicotine dependence	0.00123	0.00139	CcSEcCtD
Escitalopram—Muscle spasms—Varenicline—nicotine dependence	0.00122	0.00138	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0012	0.0102	CbGpPWpGaD
Escitalopram—Vision blurred—Varenicline—nicotine dependence	0.0012	0.00136	CcSEcCtD
Escitalopram—Tremor—Varenicline—nicotine dependence	0.00119	0.00135	CcSEcCtD
Escitalopram—Ill-defined disorder—Varenicline—nicotine dependence	0.00118	0.00133	CcSEcCtD
Escitalopram—Anaemia—Varenicline—nicotine dependence	0.00117	0.00133	CcSEcCtD
Escitalopram—Agitation—Varenicline—nicotine dependence	0.00117	0.00132	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00116	0.00993	CbGpPWpGaD
Escitalopram—Angioedema—Varenicline—nicotine dependence	0.00116	0.00131	CcSEcCtD
Escitalopram—Malaise—Varenicline—nicotine dependence	0.00114	0.0013	CcSEcCtD
Escitalopram—Vertigo—Varenicline—nicotine dependence	0.00114	0.00129	CcSEcCtD
Escitalopram—Syncope—Varenicline—nicotine dependence	0.00114	0.00129	CcSEcCtD
Escitalopram—Palpitations—Varenicline—nicotine dependence	0.00112	0.00127	CcSEcCtD
Escitalopram—Loss of consciousness—Varenicline—nicotine dependence	0.00112	0.00126	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00111	0.00952	CbGpPWpGaD
Escitalopram—Cough—Varenicline—nicotine dependence	0.00111	0.00125	CcSEcCtD
Escitalopram—Convulsion—Varenicline—nicotine dependence	0.0011	0.00125	CcSEcCtD
Escitalopram—Hypertension—Varenicline—nicotine dependence	0.0011	0.00124	CcSEcCtD
Escitalopram—Chest pain—Varenicline—nicotine dependence	0.00108	0.00122	CcSEcCtD
Escitalopram—Myalgia—Varenicline—nicotine dependence	0.00108	0.00122	CcSEcCtD
Escitalopram—Arthralgia—Varenicline—nicotine dependence	0.00108	0.00122	CcSEcCtD
Escitalopram—Anxiety—Varenicline—nicotine dependence	0.00108	0.00122	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00107	0.00122	CcSEcCtD
Escitalopram—Discomfort—Varenicline—nicotine dependence	0.00107	0.00121	CcSEcCtD
Escitalopram—Dry mouth—Varenicline—nicotine dependence	0.00106	0.0012	CcSEcCtD
Escitalopram—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00105	0.00893	CbGpPWpGaD
Escitalopram—Oedema—Varenicline—nicotine dependence	0.00104	0.00117	CcSEcCtD
Escitalopram—Infection—Varenicline—nicotine dependence	0.00103	0.00117	CcSEcCtD
Escitalopram—Shock—Varenicline—nicotine dependence	0.00102	0.00115	CcSEcCtD
Escitalopram—Nervous system disorder—Varenicline—nicotine dependence	0.00102	0.00115	CcSEcCtD
Escitalopram—Thrombocytopenia—Varenicline—nicotine dependence	0.00101	0.00115	CcSEcCtD
Escitalopram—Tachycardia—Varenicline—nicotine dependence	0.00101	0.00115	CcSEcCtD
Escitalopram—Skin disorder—Varenicline—nicotine dependence	0.00101	0.00114	CcSEcCtD
Escitalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.001	0.00857	CbGpPWpGaD
Escitalopram—Hyperhidrosis—Varenicline—nicotine dependence	0.001	0.00113	CcSEcCtD
Escitalopram—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00099	0.00845	CbGpPWpGaD
Escitalopram—Anorexia—Varenicline—nicotine dependence	0.000988	0.00112	CcSEcCtD
Escitalopram—Hypotension—Varenicline—nicotine dependence	0.000968	0.0011	CcSEcCtD
Escitalopram—SLC6A3—Neuronal System—GABRA4—nicotine dependence	0.000958	0.00818	CbGpPWpGaD
Escitalopram—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000944	0.00107	CcSEcCtD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000943	0.00805	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00094	0.00802	CbGpPWpGaD
Escitalopram—Insomnia—Varenicline—nicotine dependence	0.000937	0.00106	CcSEcCtD
Escitalopram—Dyspnoea—Varenicline—nicotine dependence	0.000924	0.00105	CcSEcCtD
Escitalopram—Somnolence—Varenicline—nicotine dependence	0.000921	0.00104	CcSEcCtD
Escitalopram—SLC6A3—Neuronal System—CHRNB4—nicotine dependence	0.000919	0.00784	CbGpPWpGaD
Escitalopram—Dyspepsia—Varenicline—nicotine dependence	0.000912	0.00103	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000909	0.00776	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000904	0.00772	CbGpPWpGaD
Escitalopram—Decreased appetite—Varenicline—nicotine dependence	0.000901	0.00102	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000894	0.00101	CcSEcCtD
Escitalopram—Fatigue—Varenicline—nicotine dependence	0.000893	0.00101	CcSEcCtD
Escitalopram—Pain—Varenicline—nicotine dependence	0.000886	0.001	CcSEcCtD
Escitalopram—Constipation—Varenicline—nicotine dependence	0.000886	0.001	CcSEcCtD
Escitalopram—SLC6A3—Neuronal System—CHRNA5—nicotine dependence	0.000854	0.00729	CbGpPWpGaD
Escitalopram—Feeling abnormal—Varenicline—nicotine dependence	0.000854	0.000967	CcSEcCtD
Escitalopram—Gastrointestinal pain—Varenicline—nicotine dependence	0.000847	0.00096	CcSEcCtD
Escitalopram—Urticaria—Varenicline—nicotine dependence	0.000823	0.000932	CcSEcCtD
Escitalopram—Abdominal pain—Varenicline—nicotine dependence	0.000819	0.000928	CcSEcCtD
Escitalopram—Body temperature increased—Varenicline—nicotine dependence	0.000819	0.000928	CcSEcCtD
Escitalopram—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000814	0.00695	CbGpPWpGaD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000814	0.00694	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000812	0.00693	CbGpPWpGaD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0008	0.00683	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000799	0.00682	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.000773	0.0066	CbGpPWpGaD
Escitalopram—Hypersensitivity—Varenicline—nicotine dependence	0.000763	0.000865	CcSEcCtD
Escitalopram—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000762	0.00651	CbGpPWpGaD
Escitalopram—Asthenia—Varenicline—nicotine dependence	0.000743	0.000842	CcSEcCtD
Escitalopram—Pruritus—Varenicline—nicotine dependence	0.000733	0.00083	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000726	0.0062	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000719	0.00613	CbGpPWpGaD
Escitalopram—Diarrhoea—Varenicline—nicotine dependence	0.000709	0.000803	CcSEcCtD
Escitalopram—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000709	0.00605	CbGpPWpGaD
Escitalopram—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000701	0.00599	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—CHRNA3—nicotine dependence	0.000696	0.00594	CbGpPWpGaD
Escitalopram—Dizziness—Varenicline—nicotine dependence	0.000685	0.000776	CcSEcCtD
Escitalopram—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000661	0.00564	CbGpPWpGaD
Escitalopram—Vomiting—Varenicline—nicotine dependence	0.000659	0.000746	CcSEcCtD
Escitalopram—Rash—Varenicline—nicotine dependence	0.000653	0.00074	CcSEcCtD
Escitalopram—Dermatitis—Varenicline—nicotine dependence	0.000653	0.000739	CcSEcCtD
Escitalopram—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000652	0.00556	CbGpPWpGaD
Escitalopram—Headache—Varenicline—nicotine dependence	0.000649	0.000735	CcSEcCtD
Escitalopram—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000626	0.00535	CbGpPWpGaD
Escitalopram—Nausea—Varenicline—nicotine dependence	0.000615	0.000697	CcSEcCtD
Escitalopram—SLC6A3—Neuronal System—CHRNB2—nicotine dependence	0.000613	0.00523	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000607	0.00518	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000582	0.00496	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—CHRNA4—nicotine dependence	0.000557	0.00475	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000531	0.00453	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000526	0.00449	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000525	0.00448	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00052	0.00444	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000516	0.00441	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000515	0.0044	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000482	0.00412	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000463	0.00395	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00046	0.00393	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000459	0.00392	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000458	0.00391	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000452	0.00386	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000451	0.00385	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000449	0.00384	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000442	0.00378	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000439	0.00375	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000432	0.00369	CbGpPWpGaD
Escitalopram—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000426	0.00364	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000418	0.00357	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000417	0.00356	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000417	0.00356	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00041	0.0035	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000396	0.00338	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00038	0.00325	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000379	0.00324	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000378	0.00323	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000376	0.00321	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000373	0.00319	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000361	0.00308	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00036	0.00307	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000354	0.00303	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000343	0.00293	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000342	0.00292	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000337	0.00288	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000328	0.0028	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000327	0.00279	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000326	0.00278	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000325	0.00277	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000322	0.00275	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00032	0.00273	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.000286	0.00245	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000285	0.00243	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000248	0.00212	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000247	0.00211	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000247	0.00211	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000246	0.0021	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000244	0.00208	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000242	0.00207	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000224	0.00191	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000224	0.00191	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000203	0.00174	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000197	0.00169	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000194	0.00166	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGD1—nicotine dependence	0.000194	0.00165	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000193	0.00165	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000193	0.00165	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00019	0.00163	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.00019	0.00162	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	0.000176	0.0015	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000176	0.0015	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000173	0.00148	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	0.000171	0.00146	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000171	0.00146	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000168	0.00143	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000162	0.00138	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	0.000147	0.00125	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	0.00014	0.0012	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.00014	0.00119	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WASF2—nicotine dependence	0.000139	0.00119	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000138	0.00117	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—WASF1—nicotine dependence	0.000133	0.00114	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—DRD2—nicotine dependence	0.000127	0.00109	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000127	0.00108	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000125	0.00107	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000123	0.00105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WASF2—nicotine dependence	0.000121	0.00103	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.00012	0.00103	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	0.00012	0.00103	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000118	0.00101	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—WASF1—nicotine dependence	0.000116	0.000987	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000115	0.000984	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000113	0.000968	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000113	0.000965	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—OPRM1—nicotine dependence	0.000104	0.000888	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000104	0.000886	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000102	0.000872	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—DRD2—nicotine dependence	8.68e-05	0.000741	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—DRD2—nicotine dependence	7.52e-05	0.000642	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—DRD2—nicotine dependence	7.5e-05	0.00064	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2A7—nicotine dependence	7.39e-05	0.000631	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	7.38e-05	0.00063	CbGpPWpGaD
